Bengaluru’s Zydus Cadila to start phase II clinical trials of COVID-19 vaccine


PTI, Aug 5, 2020, 1:53 PM IST

New Delhi/Bengaluru: Drug firm Zydus Cadila on Wednesday, August 5 said the phase I clinical trial of its COVID-19 vaccine candidate, ZyCoV-D, has been completed and it will commence phase II clinical trials from August 6.

“ZyCoV-D was found to be safe and well-tolerated in phase I clinical trial. The company will now commence phase II clinical trials from the 6th of August, 2020. The company reports that the doses of the vaccine administered to healthy volunteers in phase I clinical trial, which began on July 15, 2020, has been well-tolerated,” Cadila Healthcare, the listed entity of the group, said in a regulatory filing.

Zydus Cadila Chairman Pankaj R Patel said the phase I dosing to establish the safety of ZyCoV-D is an important milestone.

“All the subjects in phase I clinical trial were closely monitored in a clinical pharmacological unit for 24 hours post-dosing for safety and for 7 days thereafter and the vaccine was found to be very safe. We now begin the phase II clinical trials and look forward to evaluating the safety and immunogenicity of the vaccine in a larger population,” he added.

Last month, Zydus had received approval from domestic authorities to start human trials for its COVID-19 vaccine contender – the second Indian pharmaceutical firm to get such nod amid a surge in novel coronavirus infections worldwide.

It got approval a few days after India”s first indigenous COVID-19 vaccine candidate COVAXIN, developed by city-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, got the nod for human clinical trials from the Drug Controller General of India

Shares of Cadila Healthcare were trading at Rs 407.20 apiece on BSE, up 1.08 percent from its previous close.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Activist Sarah Gill becomes Pakistan’s first transgender doctor

TN farmers take out anti-Mekedatu rally, slam Karnataka Cong for padayatra

Amit Palekar, AAP’s CM face in Goa, is lawyer and social worker, newcomer in politics

Over 40 cops from KSRP’s Mysuru battalion deployed for Cong Mekedatu march test COVID positive

M’luru: Physical classes to be cancelled in schools & colleges reporting 5 or more Covid cases: DC

5G scare: Air India cancels 8 US flights; DGCA working to overcome situation

Udupi: Woman killed in road accident at Brahmavar


Related Articles More

COVID-19 health emergency could be over this year, WHO says

Centre flags decline in Covid testing, asks states to enhance it

Go for test for TB, other conditions if cough persists for more than 2-3 weeks: Revised clinical guidance for Covid patients

K’taka govt warns medical professionals of action for spreading misinformation on Covid

Some COVID-19 patients may be infectious even after ten days: Study

MUST WATCH

Man Desighned Tallest Ridable Bicycle

Groundnut Cultivation Practices / Peanut farming in India

NEWS BULLETIN 19-01-2022

Crocodile and Dead Body found in Kali river Dandeli

Highlights of Sri Krishnapura Paryaya 2022


Latest Additions

Activist Sarah Gill becomes Pakistan’s first transgender doctor

TN farmers take out anti-Mekedatu rally, slam Karnataka Cong for padayatra

Amit Palekar, AAP’s CM face in Goa, is lawyer and social worker, newcomer in politics

Over 40 cops from KSRP’s Mysuru battalion deployed for Cong Mekedatu march test COVID positive

M’luru: Physical classes to be cancelled in schools & colleges reporting 5 or more Covid cases: DC

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.